Hemo Organic share news, announcements and annual reports
BSE: 524590Commercial Services & SuppliesSmall Cap
Hemo Organic Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1994
Last close ₹21.85down ₹1.12 (4.88%)
Share price at the BSE close on 26 Oct 2026. Previous close ₹22.97.
26 Oct: open ₹22.97, high ₹22.97, low ₹21.83
52-week range of traded prices to 26 Oct 2026
₹8.29Low, 28 Oct 2025₹24.42High, 14 Jul 2026
- Under BSE's graded surveillance, stage IV, on the list for 28 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15 Cr4,997th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.61
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- −22.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −9.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.40
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 20,054
Hemo Organic board meetings
140 filed, newest first. Page 1 of 3.
Oct 2026
14 Oct · Board meeting
Meeting on 17 Oct 2026: quarterly results3 Oct · Board meeting
Sep 2026
29 Sep · Board meeting
Meeting on 3 Oct 2026: issue of warrants and preferential issue of shares25 Sep · Board meeting
Meeting on 25 Sep 202621 Sep · Board meeting
17 Sep · Board meeting
Meeting on 17 Sep 202617 Sep · Board meeting
Aug 2026
13 Aug · Board meeting
Jul 2026
10 Jul · Board meeting
Meeting on 15 Jul 2026: quarterly results
May 2026
25 May · Board meeting
Meeting on 29 May 2026: quarterly results and audited results
Mar 2026
31 Mar · Board meeting
Feb 2026
26 Feb · Board meeting
Meeting on 26 Feb 202626 Feb · Board meeting
10 Feb · Board meeting
Meeting on 13 Feb 2026: quarterly results
Dec 2025
11 Dec · Board meeting
8 Dec · Board meeting
Meeting on 11 Dec 2025: issue of warrants and preferential issue of shares
Nov 2025
11 Nov · Board meeting
Meeting on 14 Nov 2025: preferential issue of shares and quarterly results
Aug 2025
7 Aug · Board meeting
Meeting on 13 Aug 2025: quarterly results
Jun 2025
27 Jun · Board meeting
May 2025
20 May · Board meeting
16 May · Board meeting
Meeting on 20 May 2025: audited results and quarterly results
Mar 2025
31 Mar · Board meeting
Feb 2025
3 Feb · Board meeting
Meeting on 6 Feb 2025: quarterly results
Dec 2024
26 Dec · Board meeting
20 Dec · Board meeting
Meeting on 26 Dec 2024: rights issue of equity shares
Oct 2024
23 Oct · Board meeting
Meeting on 28 Oct 2024: quarterly results
Aug 2024
14 Aug · Board meeting
6 Aug · Board meeting
Meeting on 12 Aug 2024: quarterly results
May 2024
22 May · Board meeting
Meeting on 29 May 2024: audited results and quarterly results
Apr 2024
18 Apr · Board meeting
Meeting on 18 Apr 2024